摘要
目的了解老年非小细胞肺癌化疗患者述情障碍水平及相关影响因素。方法采用一般情况调查表、述情障碍量表(TAS-20)、Tilburg衰弱量表、阿森斯失眠量表(AIS)对老年非小细胞肺癌化疗患者进行问卷调查,并采用单因素及logistic回归分析老年非小细胞肺癌化疗患者述情障碍的相关影响因素。结果老年非小细胞肺癌化疗患者述情障碍发生率为45.06%(114/253)。单因素分析显示,年龄、居住地、文化程度、病理分期、化疗周期、是否伴有衰弱、睡眠障碍与患者述情障碍的发生存在关联(χ^(2)分别=24.63、10.58、25.09、8.23、10.42、15.71、22.56,P均<0.05),logistic回归分析结果显示,高龄、文化程度低、居住农村、化疗周期长、衰弱、存在睡眠障碍是老年非小细胞肺癌化疗患者述情障碍的危险因素(P均<0.05)。结论老年非小细胞肺癌化疗患者存在较为明显的述情障碍,临床应加强关注高龄、文化程度低、居住农村、化疗周期较长、合并衰弱的患者情感表达,改善患者睡眠质量有助于减少述情障碍的发生。
Objective To investigate the alexithymia level and related influencing factors in elderly patients with nonsmall cell lung cancer(NSCLC)undergoing chemotherapy. Methods The elderly patients with NSCLC were investigated by general situation questionnaire,alexithymia scale(TAS-20),tillburg decline scale and AIS.The related factors of alexithymia were analyzed by logistic regression. Results The incidence of alexithymia in elderly patients with NSCLC chemotherapy was 45.06%(114/253).The single factor analysis showed that age,residence,education,pathological stage,chemotherapy cycle,whether there were weakness or not,sleep disorder were correlated with the occurrence of alexithymia(χ2=24.63,10.58,25.09,8.23,10.42,15.71,22.56,P<0.05).Logistic regression analysis showed that advanced age,poor education,living in rural areas,longer chemotherapy cycle,weakness,sleep disorder were the risk factors of alexithymia in elderly patients with NSCLC(P<0.05). Conclusion The elderly patients with non-small cell lung cancer after chemotherapy have obvious alexithymia.We should pay more attention to the emotional expression of elderly patients with poor education,living in rural areas,longer chemotherapy cycle,weakness,and sleep disorder.
作者
郑露
郑杉
JIANG Hong
ZHENG Lu;ZHENG Shan;JIANG Hong(Department of Cardiothoracic Surgery,Hangzhou First People's Hospital Affiliated to Medical College of Zhejiang University,Hangzhou 310006,China.)
出处
《全科医学临床与教育》
2021年第6期509-511,515,共4页
Clinical Education of General Practice
基金
浙江省自然基金项目(LGF21H160021)。
关键词
老年
非小细胞肺癌
化疗
述情障碍
影响因素
elderly
non smallcelllungcancer
chemotherapy
alexithymia
influencing factors